The T-Stenting and Small Protrusion Technique for Bifurcation Lesions
The T-Stenting and Small Protrusion Technique for Bifurcation Lesions
The T-Stenting and Small Protrusion Technique for Bifurcation Lesions
Transform your PDFs into Flipbooks and boost your revenue!
Leverage SEO-optimized Flipbooks, powerful backlinks, and multimedia content to professionally showcase your products and significantly increase your reach.
<strong>The</strong> T-<strong>Stenting</strong> <strong>and</strong> <strong>Small</strong> <strong>Protrusion</strong><br />
<strong>Technique</strong> <strong>for</strong> <strong>Bifurcation</strong> <strong>Lesions</strong><br />
(TAP-<strong>Stenting</strong>)<br />
Beijing Capital University<br />
Beijing Anzhen Hospital<br />
Zhou Yujie
Strategies on bifurcation lesions
DES <strong>Bifurcation</strong> <strong>Technique</strong><br />
Provisional side Two-stent strategy<br />
-branch strategy<br />
Stent implantation in the<br />
main branch <strong>and</strong> optional<br />
stent implantation at SB<br />
Stent implatation at both the<br />
main vessel <strong>and</strong> side branch<br />
• Crush<br />
• Provisional T-stenting<br />
• Reverse Crush<br />
• T stenting<br />
• Culotte<br />
• TAP<br />
• SKS<br />
• Y stenting
Nordic <strong>Bifurcation</strong> Study (n=413)<br />
Two-stent strategy (n=206)<br />
<strong>Stenting</strong> of the main vessel <strong>and</strong> side<br />
413 pts with<br />
bifurcation<br />
lesion<br />
R<strong>and</strong>omized<br />
branch (MV+SB)<br />
Provisional side-brach strategy (n=207)<br />
<strong>Stenting</strong> of the main vessel <strong>and</strong> optional<br />
stenting of the side branch (MV)<br />
Primary Endpoint: Major adverse cardiac event (MACE) at 6 months
Nordic <strong>Bifurcation</strong> Study (n=413)<br />
Primary Endpoint of MACE at 6 months (%)<br />
p=NS<br />
20%<br />
10%<br />
17.7%<br />
12.7%<br />
• <strong>The</strong>re was no<br />
difference in major<br />
adverse cardiac<br />
events at 6 months<br />
(17.7% vs 12.7%;<br />
p=NS)<br />
0%<br />
MV+SB group<br />
MV group<br />
Presented at ACC 2006
Nordic <strong>Bifurcation</strong> Study (n=413)<br />
Procedure Related Myocardial Infarction (%)<br />
15%<br />
13%<br />
10%<br />
p=0.008<br />
• Procedure related<br />
MI was defined as a<br />
five-fold fold elevation of<br />
biochemical<br />
markers<br />
5%<br />
0%<br />
MV+SB group<br />
4%<br />
MV group<br />
• Procedure related<br />
MI occurred more<br />
than three times as<br />
often in the MV+SB<br />
group (13% vs 4%;<br />
p=0.008)<br />
Presented at ACC 2006
Current opinions on PCI <strong>for</strong> bifurcation disease<br />
Optimal treatment of bifurcation disease has yet to<br />
be established<br />
<strong>The</strong> two-stent strategy offer no clinical advantage<br />
compared with the provisional side-branch strategy<br />
Provisional side-branch strategy is the most commonly<br />
adopted technique
Provisional side-branch strategy<br />
Provisional T-stenting<br />
Reverse Crush<br />
TAP<br />
• A sizable proportion of patients does require a stent<br />
on SB even if the intention is to try to avoid it<br />
• In TULIP study, a 34% rate of SB stenting has been<br />
reported (Brunel P, et al. Catheter Cardiovasc Interv<br />
2006;68:67-73)
<strong>The</strong> probelms of provisional T-stenting<br />
Bench Testing of provisional T-stenting<br />
A<br />
B
<strong>The</strong> probelms of provisional T-stenting<br />
It was difficult to place the side-branch<br />
stent precisely<br />
Deployment too distally leaves large<br />
gaps, which may lead to<br />
may lead to incomplete coverage<br />
of the ostium of the SB<br />
Deployment too proximally potentially<br />
obstructs the main branch
<strong>The</strong> probelms of Reverse Crush<br />
Bench Testing of Reverse Crush
Disadvantages of Reverse Crush<br />
• Accumulation of stent struts at the ostium of SB<br />
which could increase the risk of stent thrombosis<br />
• <strong>The</strong> need to re-cross multiple struts with a wire <strong>and</strong><br />
balloon makes the procedure more laborious
Model presentation of TAP technique
TAP technique<br />
Wire both branches<br />
<strong>and</strong> predilate<br />
Deploy stent in<br />
main branch
Wire side branch <strong>and</strong><br />
dilate<br />
Kissing balloon
SB stent<br />
positioning<br />
SB stent is<br />
deployed with the<br />
uninflated balloon<br />
into the MV
<strong>The</strong> balloon of<br />
the SB stent is<br />
slightly retrieved<br />
<strong>and</strong> aligned to<br />
the MV balloon<br />
Final kissing<br />
balloon
In vitro TAP stenting<br />
Perfect coverage of the<br />
bifurcation with<br />
minimal stent’s struts<br />
overlap at the proximal<br />
part of SB ostium
IVUS Image<br />
IVUS<br />
image of<br />
the main<br />
branch<br />
showing<br />
neocarina<br />
about 3<br />
mm in<br />
length
Advantages of the TAP technique<br />
Complete coverage of the vessel<br />
wall including the ostium of the SB<br />
Reduce the risk of SB ostium restenosis<br />
Without large multiple stent layers<br />
Reduce the risk of stent thrombosis
Differences between the Mini-<br />
Crush <strong>and</strong> the TAP technique
Mini-Crush is not a provisional side-branch strategy!
Differences between the Reverse<br />
Crush <strong>and</strong> the TAP technique
Reverse crushing technique<br />
Wire both<br />
branches <strong>and</strong><br />
predilate<br />
Deploy stent in<br />
main branch
Wire side branch <strong>and</strong><br />
dilate<br />
Position stent in side<br />
branch protruding<br />
in MB (3-5mm),<br />
leave a balloon in<br />
MB
Deploy stent in<br />
the side branch<br />
<strong>and</strong> remove wire<br />
<strong>and</strong> balloon<br />
Crush the<br />
protruding part of<br />
SB on top of the<br />
stent in MB
Rewire the side branch<br />
<strong>and</strong> per<strong>for</strong>m highpressure<br />
dilatation<br />
Kissing at medium<br />
pressure
6F<br />
Tips <strong>and</strong> tricks<br />
Size of Guiding Catheter<br />
7F<br />
8F<br />
0.070”<br />
0.071’’<br />
0.078”<br />
0.088”<br />
MV balloon shaft profile + SB stent shaft profile<br />
≤5.3F<br />
5.4F ~5.9F<br />
≥6.0F<br />
GC<br />
6 F 7 F 8 F
球 囊 种 类<br />
(≤3.5mm)<br />
推 送 杆 外 径<br />
Maverick 2 2.0F<br />
Ryujin 2.5F<br />
SeQuent 2.5F<br />
Avita 2.55F<br />
Sprinter 2.6F<br />
Crosssail 2.6F<br />
Kingou 2.6F<br />
Aqua T3 2.7F<br />
Powersail 2.9F<br />
AVION<br />
2.8F<br />
Extensor<br />
3.0<br />
Voyager<br />
2.7<br />
Grip<br />
2.6<br />
CTO<br />
2.5<br />
6F 导 引 导 管 进 行 球 囊 对 吻 技 术<br />
6F 导 引 导 管 的 内 径 :0.070〞<br />
0.071)<br />
5.4F>0.070″>5.3F<br />
6F 导 管 完 成 对 吻 扩 张<br />
两 球 囊 推 送 杆 外 径 之 和 应 ≤5.3F
选 用 导 引 导 管 :6F JL 3.5<br />
球 囊 外 径 :2.9F+2.6F=5.5F<br />
6F 导 管 内 径 :0.070 inch
Tips <strong>and</strong> tricks<br />
<strong>The</strong> optimal visualization of the stent is important<br />
<strong>for</strong> the precise positioning of SB stent, so stent with<br />
higher radio-opacity (such as Cypher) is preferable<br />
Good expansion of the MV stent <strong>and</strong> optimal<br />
predilation of the SB ostium could facilitate the<br />
advancement of the SB stent
Case of TAP stenting
Coronary Angiography
6F EBU 3.5<br />
BMW<br />
BMW<br />
3.0×24mm<br />
Cypher
Kissing balloon after<br />
rewiring of SB<br />
Deployment MV stent<br />
with jailed guidewire<br />
into the SB
SB stent positioning<br />
MV balloon<br />
SB stent<br />
<strong>The</strong> position of the<br />
SB stent is<br />
adjusted to fully<br />
cover the proximal<br />
part of the SB<br />
ostium (red arrow)<br />
while an<br />
uninflated balloon<br />
kept into the MV
SB stent deployment<br />
SB is deployed with<br />
the uninflated<br />
balloon into MV
Final kissing balloon<br />
<strong>The</strong> balloon of the<br />
SB stent is slightly<br />
retrieved <strong>and</strong><br />
aligned to the MV<br />
balloon<br />
Final kissing balloon<br />
SB stent’s balloon<br />
+ MV balloon
Final Result
Clinical study of TAP<br />
Burzotta F, et al.<br />
Catheterization <strong>and</strong> Cardiovascular<br />
Interventions 2007, 70:75–82
Angiographic characteristics<br />
Target lesion n=61<br />
Distal LM 26<br />
LAD/diagonal 28<br />
LCX/OM 5<br />
RCA/descending posterior 2<br />
Angulation between main <strong>and</strong> side-branch<br />
Angle70° 26
Procedure characteristics<br />
Approach<br />
Transradial 24<br />
Transfemoral 37<br />
Guiding catheter size<br />
6 Fr<br />
2<br />
7 Fr 25<br />
8 Fr 34<br />
Procedure time<br />
112±52min
Clinical outcome (9 month)<br />
MACE 4 (6.6%)<br />
Death 1 (1.6%)<br />
Myocardial infarction 0<br />
TLR 3 (4.9%)<br />
Stent thrombosis<br />
Definited 1 (1.6%)<br />
Suspected 1 (1.6%)<br />
Patients without MACE 56 (91.8%)
Thank you<br />
<strong>for</strong> your attention!